Relationship between prior inhaled corticosteroid use and benefits of budesonide/glycopyrronium/formoterol fumarate dihydrate on exacerbations, symptoms, health-related quality of life, and lung function in patients with chronic obstructive pulmonary disease: Analyses from the ETHOS study

Dave Singh,Klaus F Rabe,Fernando J Martinez,Matthias Krüll,Martin Jenkins,Mehul Patel,Paul Dorinsky

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE（2022）

引用 1|浏览9

暂无评分

摘要

•BGF 320 demonstrated benefits versus dual therapy, irrespective of prior ICS use.•The BGF 320 safety profile was similar in patients with and without prior ICS use.•Similar trends were observed for BGF 160.

查看译文

关键词

Budesonide/glycopyrronium/formoterol fumarate dihydrate,Chronic obstructive pulmonary disease,Inhaled corticosteroids,Triple therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要